We’re going to party “like it’s 2999” when we find the high tech and medical solutions that equal a cure for autoimmune diseases like Type 1 diabetes.
In the meantime, interested humans need to step up and participate in clinical trials. Corengi, a company developing tools to help people find clinical research studies to participate in, has built a tool that makes it easy to locate clinical research study opportunities. Corengi’s database is currently highlighting Type 2 diabetes, but the tool will be changing soon to include Type 1 diabetes.
Corengi is dedicated to helping individuals discover more about clinical trials that may be appropriate for them. Corengi is committed to building a comprehensive, free, and interactive platform for a variety of diseases. This platform will allow stakeholders within the clinical trials community (investigators, site personnel, sponsors, and disease advocates) to engage with potential enrollees and educate them about specific clinical trials
A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials and observational studies. ClinicalTrials.gov includes both interventional and observational studies.
In a clinical trial (also called an interventional study), participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants’ behavior, for example, diet. Clinical trials may compare a new medical approach to a standard one that is already available or to a placebo that contains no active ingredients or to no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. For example, investigators may give a drug or treatment to participants who have high blood pressure to see whether their blood pressure decreases.
Note: Some people who are not eligible to participate in a clinical trial may be able to get experimental drugs or devices outside of a clinical trial through an Expanded Access Program. See more information on expanded access from the National Library of Medicine.